MAPT and Alzheimer disease: The results showed that the plasma exosomal Aβ42/40, Tau, and P‐T181‐tau levels of the aMCI and AD groups were significantly higher than those of the SCD group, control group, and VaD group, and those of the AD groups were higher than those of the aMCI group.